(sialidase deficiency with a partial j3-galactosidase deficiency), Tay-Sachs disease, Gaucher disease, Hurler syndrome, Scheie syndrome and I-cell disease -and from 20 of their obligate heterozygotes.
No activity of enzymes that were deficient in the respective disease, except I-cell disease, was detected in the lymphoblastoid cells from the patient.
In I-cell disease, the cells showed lower levels of some enzyme activities.
/9-D-Galactosidase activity from heterozygotes of the patient with GMI-gangliosidosis and o-L-iduronidase activity from heterozygotes of the patient with Hurler syndrome were in carrier range.
On sephadex G-150 gel filtration, fl-D-galactosidase in control material gave two peaks (I and II) . In GMI-gangliosidosis, peak II was absent and peak I was markedly diminished.
Peak II in the heterozygotes was smaller than that of control. On DEAE cellulose column chromatography of hexosaminidase, two major isoenzymes (hexosaminidase A and B) were detected in control.
However, hexosaminidase A was not detected in Tay-Sachs disease, and the ratios of hexosaminidase (Hex) A/Hex B in the parents were lower than those in control. lymphoblastoid cell lines; lysosomal enzymes; Epstein-Barr virus; lysosomal storage diseases
Long-term lymphoblastoid cell lines have been used in the studies of inborn errors of metabolism for the past 10 years (Turner et al. 1974 (Turner et al. , 1977 Beratis et al . 1975; Glade and Beratis 1976; Minami et al. 1978) . Such cell lines can be established from a small amount of human peripheral lymphocytes by transformation with Epstein-Barr virus (EBV) (Katsuki and Hinuma 1975) . These cell systems have several advantages compared with cultured skin fibroblast cell lines. For example, once established, they are genetically stable and have unlimited life span. They also grow rapidly, which facilitates collection of large amounts of materials . Since they grow in suspension, the cells can be safely and readily harvested . They can also be stored by freezing to reestablish future cultures without difficulty (Povey et al. 1973; Beratis et al. 1975; Glade and Beratis 1976; Swallow et al. 1977; Seegmiller 1978) .
In this paper, first, we attempted to establish optimal assay conditions of eight lysosomal enzymes (c -L-fucosidase, f -D-galactosidase, a-D-mannosidase, Nacetyl-/3-D-glucosaminidase, 1i-D-glucosidase, a-D-galactosidase, /3-D-glucuronidase and a-L-iduronidase) to observe whether there are any differences in properties of these enzymes between lymphoblastoid cells, lymphocytes and granulocytes. Secondly, we assayed these enzyme activities in lymphoblastoid cells derived from patient and their obligate heterozygotes with inherited lysosomal storage disease.
MATERIALS AND METHODS
Subjects. Blood samples were collected from eleven patients -two cases of GMIgangliosidosis, a case of variant of j9-galactosidase deficiency (sialidase deficiency with a partial /3-galactosidase defect, previously reported by Orii et al. 1972 ), a case of TaySachs disease, two cases of Gaucher disease, three cases of I-cell disease, a case of Hurler syndrome and a case of Scheie syndrome -as well as from twenty of their obligate heterozygotes and twenty control subjects. All the patients were diagnosed clinically and the diagnosis was confirmed by biochemical analysis.
Lymphoblastoid cell lines. Lymphocytes were separated from heparinized peripheral blood by gradient centrifugation with Ficoll-Paque (Pharmacia Fine Chemicals). After the lymphocyte pellet was washed twice with medium RPMI 1640, cells were resuspended in this medium supplemented with 20% fetal calf serum, 100 µg/ml streptomycin and 100 IU/ ml penicillin to give 1.2 X 106 cells/ml. To 0.8 ml of lymphocyte suspension, 0.2 ml of EBV suspension (derived from culture fluid of B95-8 established lymphoblastoid cells originated from marmoset monkey; Miller and Lipman 1973) was added. The lymphocyte cultures were incubated at 37°C and half volume of medium was changed every 4 or 5 days (Katsuki and Hinuma 1975) . Cells were harvested by centrifugation at 3,000 rpm. Cells were washed twice with 0.9% saline and stored as pellets at -80°C until analysis.
Lymphocytes. The lymphocytes were separated from 10 ml of heparinized peripheral blood by gradient centrifugation with Ficoll-Paque. The cell pellets were washed twice with 0.9% saline. A few contaminating red blood cells were lysed by the addition of 3 ml of distilled water, and the solution was retured to isotonicity with 1 ml of 3.6% sodium chloride after 60 sec. After centrifugation, the lymphocyte pellets were stored at -80°C until required.
Granulocytes. A disposable plastic syringe containing heparinized peripheral blood was held in an upright position at room temperature for 60 min. The plasma containing leukocytes was carefully layered over Ficoll-Paque, then centrifuged at 3,000 rpm (plasma and Ficoll-Paque, 1:1). The cell pellets were suspended in 0.9% saline and washed twice as described above. After centrifugation, the granulocytes were stored as cell pellets at -80°C until analysis.
Sample preparation. To the cell pellets of lymphoblastoid cells, lymphocytes and granulocytes, was added an aliquot of ice-cold distilled water. The mixtures were then treated with a sonicator (Branson, Sonifier, Cell Disruptor 200) for 30 sec and the resulting suspensions were kept at 0°C until used for the enzyme assay.
Assay of enzyme. All assays were carried out using fluorometric technique with 4-methylumbelliferyl (4 MU) derivatives (Koch-Light). The following systems were used to examine the pH optima of the eight lysosomal enzymes : a-L-fucosidase, 0.1 ml of 0.1 M citrate-phosphate buffer, 0.1 ml of enzyme source, 0.4 ml of 1mM 4MU-a-L-fucopyranoside; /9-D-galactosidase, 0.1 ml of 0.1 M citrate-phosphate buffer, 0.1 ml of enzyme source, 0.4 ml of 0.8 mM 4 MU-jl-D-galactopyranoside containing 50 mM NaCI; a-D-mannosidase, 0.1 ml of 0.1 M citrate phosphate buffer, 0.1 ml of enzyme source, 0.4 ml of 1 mM 4MU-a-Dmannopyranoside; N-acetyl-j9-D-glucosaminidase (total hexosaminidase), 0.1 ml of 0.1 M citrate-phosphate buffer, 0.1 ml of enzyme source, 0.4 ml of 1 mM 4MU-2-acetamido-2-deoxy-3-D -glucopyranoside; / -D-glucosidase, 0.1 ml of 0.1 M citrate-phosphate buffer, 0.1 ml of enzyme source, 0.4 ml of 1 mM 4MU-/3-D-glucopyranoside containing sodium taurocholate (0.6 g/100 ml) (Peters et al. 1975 ); a-D-galactosidae, 0.1 ml of 0.1 M citratephosphate buffer, 0.1 ml of enzyme source, 0.4 ml of 1 mM 4MU-a-D-galactopyranoside; 9-D-glucuronidase, 0.1 ml of 0.1 M citrate-phosphate buffer, 0.1 ml of enzyme source, 0.4 ml of 1 mM 4MU-/3-D-glucuronide; a-L-iduronidase, the assay was made according to the method described by Hopwood et al. (1979) , i.e, 20,u1 of 0.1 M sodium-formate buffer containing 12 mM D-saccharic acid-l,4-lactone (Sigma chemical Co.), 20,u1 of enzyme source, 20,ul of 2 mM 4MU-a-L-iduronide. Each incubation was carried out at 37°C for 60 min. The reaction was stopped by addition of 3 ml of 0.25 M glycine buffer, pH 10.7, except for a-L-iduronidase for which 1.5 ml of the buffer was used. Fluorescence was read immediately with a Hitachi spectrophotofluorometer (Model MPF-4) with an excitation wavelength 365 nm and an emission wavelength 450 nm.
Protein was assayed according to the method of Lowry et al. (1951) . After determination of optimal pH, optimal substrate concentration for maximum activity of each enzyme was examined in the same manner as described above at optimal pH. Activities of eight lysosomal enzymes in control, patients and obligate heterozygotes were then measured under the optimal assay conditions.
Gel filtration. Lymphoblastoid cell pellet (About 3-5 mg as protein) in an aliquot of distilled water was sonicated for 30 sec, then centrifuged at 20,000 X g for 30 min. The supernatant fluid was applied to a column (1.5 X 95 cm) of Sephadex G-150 equilibrated with 0.05 M phosphate buffer, pH 7.0, and fractions of 1.5 ml were collected at a flow rate of 4.5 ml/hr. Chromatography was carried out at 4°C. f -D-Galactosidase activity was determined as follows: 0.1 ml of the elute fraction was incubated with 0.5 ml of 0.8 mM 4MU-f1-D-galactopyranoside in 0.1 M citrate-phosphate buffer containing 50 mM NaCI, at pH 4.0 for 60 min. Ratio of peak II/peak I was obtained as follows : The amounts of peak I and peak II were calculated as the sum of fluorescence activities in respective peak areas of the elute fractions, and the ratio of two values was adopted.
Ion-exchange chromatography. Samples from lymphoblastoid pellet (about 2-3 mg as protein) were prepared in the same manner as described for gel filtration. Whatman DEAE cellulose (type DE 52) was equilibrated with 10 mM citrate-phosphate buffer, pH 6.0, and packed in a column (1 X 10 cm). After sample application, the column was washed with 60 ml of the equilibration buffer, then eluted with a linear KCl gradient (0-0.2 M) in 120 ml of the same buffer. Fractions of 3.0 ml were collected at a flow rate of 50 ml/hr. Chromatography was carried out at 4°C. Each fraction was assayed for N-acetyl-f-Dglucosaminidase as follows : 0.1 ml of the elute fraction was incubated with 0.5 ml of 2 mM 4MU-N-acetyl-fl-D-glucosaminide in 0.1 M citrate-phosphate buffer, at pH 4.0 for 60 mm. Ratio of Hex A/Hex B was obtained in the same manner as ratio of peak II/peak I described for gel filtration.
RESULTS

Optimal enzyme assay condition
The pH activity profiles for each enzyme in lymphoblastoid cells, lymphocytes and granulocytes are shown in Fig. 1 . The optimal pis for a-L-iduronidase, Nacetyl-9-D-glucosaminidase, a-D-mannosidase, /9-D-galactosidase and fl-D-glucuronidase of lymphoblastoid cells were the same as those for the enzymes of lymphocytes and granulocytes : 3.0, 4.0 or 4.5. The pH optima for fl-D-glucosidase and a-D-galactosidase were 6 N 6.5 and 4 N 4.5, respectively, which differed slightly from those in lymphocytes or granulocytes. The optimum for a-L-fucosidase in lymphoblastoid cells was 6.5; this value was considerably higher than the pH optima of 5.0 and 4.5 obtained in lymphocytes and granulocytes. However, the enzyme in lymphocytes and granulocytes as well as in lymphoblastoid cells showed a considerably high activity in the pH range of 5.0 to 7.0.
The Km values of all the enzymes derived from lymphoblastoid cells were almost identical to those for the enzymes obtained from lymphocytes and granulocytes (Table 1 ). The eight lysosomal enzyme activities of lymphoblastoid cells, lymphocytes and granulocytes were assayed under the conditions listed in Table 2 . In lymphoblastoid cells derived from normal individuals, all eight enzymes were detectable though the levels of some enzymes differed from those in lymphocytes or granulocytes. Fig. 2 illustrates the observed activities of these eight enzymes in control lymphoblastoid cells, lymphocytes and granulocytes. The mean activities of a-L-fucosidase and -D-glucosidase in lymphoblastoid cells were 137.7 ±55.2 nmoles/mg protein/hr and 9.14 ± 3.28, respectively. These values were significantly greater (p < 0.05) than those in granulocytes which were 31.5± 6.9 and 4.15 ± 0.75, respectively, and also than those in lymphocytes which were 46.9 ± 11.9 and 6.18 ± 1.30. However, the levels of these enzyme activities in lymphoblastoid cells were more variable than those in lymphocytes and granulocytes.
On the other hand, an opposite tendency was found for /9-D-glucuronidase. The mean activity of this enzyme in lymphoblastoid cells (41.3±9.7 nmoles/mg protein/hr) was significantly lower (p < 0.05) than that in lymphocytes (131.9 ± The level of a-D-galactosidase in lymphoblastoid cells (52.7 ± 10.3 nmolesf mg protein/hr) was significantly higher (p<0.05) than that in lymphocytes (33.2 ± 8.7) or in granulocytes (39.7 ± 8.5). The level of N-acetyl-/3-D-glucosaminidase in lymphoblastoid cells (610.6 ± 159.2) was significantly lower (p<0.05) than that in lymphocytes (1102.3 ±242.2) or in granulocytes (742. 4 ± 190.3) . The activity of 9-D-galactosidase showed a pattern similar to N-acetyl-3-D-glucosaminidase, though its variation was not so uniform. The levels of this enzyme in lymphoblastoid cells, lymphocytes and granulocytes were 79.2 ± 17.9 nmoles/mg protein/hr, 216.8±49.0 and 126.3±32.9, respectively.
With respect to a-D-mannosidase, the level in lymphoblastoid cells (102.9 ± 55.0 nmolesf mg protein/hr) was lower than that in granulocytes (150.1 ± 45.5), but similar to that in lymphocytes (96.8±36.7).
Unfortunately, our stock of 4MU-a-D-iduronide was so small in amount that we could measure a-L-iduromdase activity in only 5 control sets, whereas 20 sets of samples were examined for other enzymes. Although the number of samples was too small to evaluate the data statistically, the level in lymphoblastoid cells (1.11 ± 0.41 nmolesf mg protein/hr) appeared to be considerably lower than that in lymphocytes (18.7±6.7) and in granulocytes (16.7±4.1).
In our materials, lymphocytes showed higher activities of /3-D-glucosidase, a-L-fucosidase, ~3-D-galactosidase and N-acetyl-9-D-glucosaminidase than granulocytes, while the activities of a-D-mannosidase, /3-D-glucuronidase and a-D-galctosidase were lower in lymphocytes than in granulocytes. These observations were in good agreement with those of Beutler et al. (1976) . 19-D-Galactosidase activity in lymphoblastoid cells from the patients with GMIgangliosidosis was markedly reduced. The levels in their obligate heterozygotes were all within carrier range. Lymphoblastoid cells from the patient who was diagnosed as a variant of /3-D-galactosidase deficiency showed a 38% activity of the control value (Table 3 ). p11 optima of this enzyme in Cases 1 and 2 were 4 N 4.5. There was no difference in pH optimum between specimens from the patients and from his parents (Fig. 3) .
On Sephadex G-150 gel filtration, j9-D-galactosidase gave two peaks (peak I and peak II) in control. In a case of GMI-gangliosidosis, peak II was not detectable and only a small pcak I was observed. In obligate heterozygotes peak II was smaller than that in control. The ratios of peak II/peak I were as follows; control 0.66, father of Case 1 0.28, mother of Case 1 0.47, father of Case 2 0.28, mother of Case 2 0.53. A variant of /9-D-galactosidase deficiency showed peak II, which was undetectable in GMI-gangliosidosis, Peak I in this case of fl-galactosidase deficiency was reduced to a level similar to that in GMI-gangliosidosis. In heterozygotes of the patient with a variant of /3-galactosidase deficiency, the father showed the pattern similar to control, whereas the mother showed a smaller peak II than that in control. The ratios of peak II/peak I in father and mother were 0.67 and 0.46, respectively (Fig. 4) . Table 4 shows /3-D-glucosidase activity in the patients with Gaudier disease. The activity in the patients' lymphoblastoid cells was markedly reduced. The elder sister showed a higher activity (22% of control) than the brother (14% of control). The level in mother was within carrier range, while that in father was within normal range. The pH optimum of /3-D-glucosidase in the patients' lymphoblastoid cells was 6.5. This slight shift of pH optimum towards the neutral side was also observed in mother, while father showed the same pH optimum as in control (Fig. 5) . Total hexosaminidase (Hex; N-acetyl-j3-D-glucosaminidase) activity in the patients with Tay-Sachs disease was within normal range. DEAE cellulose column chromatography revealed the occurrence of two major isoenzymes (Hex B and A) in the control lymphoblastoid cells. On the other hand, Hex A was completely absent in Tay-Sachs disease (Fig. 6 ). Although the parents showed the same isoenzyme pattern as in control, the ratios of Hex A/Hex B were lower than in control (Table 5) . a-L-Iduronidase activity was undetectable in lymphoblastoid cells from the patient with Hurler syndrome. The levels in lymphoblastoid cells from the parents and the younger sister were clearly within carrier range. In Scheie syndrome, there was a marked deficiency in a-L-Iduronidase activity (3.6% of control), but the activity in the parents was within normal range (Table 6 ).
The activities of several acid-hydrolases in lymphoblastoid cells from the patients with I-cell disease also differed from those in control specimens. In Case 3, the activities of four of the seven enzymes -a-D-mannosidase (28% of control), /3-D-galactosidase (29%), N-acetyl-/3-n-glucosaminidase (67%) and a-D-galactosidase (55%) -were lower than those in the control. In Case 1, the activities of only two enzymes --n-glucosidase (42%) and a-n-galactosidase (64%) -were reduced. In Case 2, only the activity of N-acetyl-~-D-glucosaminidase (65%) was low. In obligate heterozygotes, lower activities were observed for a-L-fucosidase in Case 2 mother an Case 3 father, for a-D-glactosidase in Case 1 mother and Case 3 father, and for N-acetyl-3-D-glucosaminidase in Case 1 mother (Table 7) .
DISCUSSION
All enzymes assayed in this study, except a-L-fucosidase, in control lymphoblastoid cells had pH optima and Km values similar to those in lymphocytes and granulocytes. The pH optimum and the pH activity curve of a-L-fucosidase in control lymphoblastoid cells were different from those in control lymphocytes and granulocytes, though all three types of cells showed generally high activities in the pH range of 5.0 N 7.0. The reason for the difference between lymphoblastoid cells and peripheral white blood cells is unclear. Turner et al. (1975) demonstrated a polymorphism of a-L-fucosidase in both leukocytes and lymphoblastoid cell lines using isoelectric focusing in acrylamide gel. The difference in pH optimum observed in the present study may reflect variation in isoenzyme pattern, but further investigation is required to make it clear. Glade and Beratis (1976) reported that these cells express the genotype of the donors and that they can be useful for the diagnosis of fucosidosis, because a-L-fucosidase activity was barely detectable in fucosidosis.
The control values of /9-D-glucosidase and a-L-fucosidase in lymphoblastoid cells varied beyond the range of the values in lymphocytes and granulocytes, whereas -D-glucuronidase varied only slightly. Swallow et al. (1977) and Turner et al. (1977) also reported similar variations. These findings cannot easily be explained. Although viability of each cell line at harvesting was almost within a range from 80 to 90% in the present study, slight differences in the viability may affect the enzyme stability to different extents, in addition to differences in respective enzyme activity in individual cells. However, it should be noted that Matsuda et al. (1977) demonstrated several different profiles of enzyme activity during cell growth. They suggested that non-viable cells still possessed a-Lfucosidase activity 3 to 5 days after subculture. The eight enzyme assayed in lymphoblastoid cells could be classified into two groups; the one showing higher activities than those in lymphocytes and granulocytes, and the other showing lower activities. In particular, the activities of a-Liduronidase and -D-glucuronidase in lymphoblastoid cells were considerably lower. However, the activity of a-L-iduronidase was found to be deficient in the patients with Hurler syndrome or Scheie syndrome and moreover, no overlap of the enzyme level was seen between lymphoblastoid cells from control individuals and from obligate heterozygotes of Hurler syndrome.
On Sephadex G-150 gel filtration of fl-D-galactosidase of lymphoblastoid cells, it was found that in GMI-gangliosidosis, peak I was reduced to about 5% of control and peak II was apparently absent. The level of peak II in obligate heterozygotes tended to be smaller than those in control, and the reduced levels of j9-D-galactosidase in the obligate heterozygotes were thought to be due mainly to greater loss of peak II activity. These findings suggest that peak II may function mainly in degradation of GMI-ganglioside.
Interesting differences were observed in the pattern of -D-galactosidase in lymphoblastoid cells between the patients who were diagnosed as a variant of ~9-galactosidase deficiency and as GMI-gangliosidosis. The activity in lymphoblastoid cells of the former patient was 6% of the control in peak I and 40% of the control in peak II. Sephadex G-150 gel filtration of ,3-D-galactosidase in the liver revealed three isoenzymes (peaks I, II and III) in control, and a lack of peak I, low level of peak II and high level of peak III in this particular case of /9-galactosidase deficiency (Orii et al. 1975) . Moreover, in this case GMI-ganglioside /9-galactosidase activity in the liver was 21.8-29.6% of the control value. Consequently, this case was considered as an incomplete deficiency of acidic /9-Dgalactosidase. /9-D-Galactosidase levels in lymphoblastoid cells from his parents were normal, although his mother showed a smaller peak II of /9-D-galactosidase than in control on Sephadex G-150 gel filtration. f3-D-Galactosidase activity in leukocytes from this patient was 6% of control and the activity in lymphoblastoid cells was elevated to 38% of control. On the other hand, levels of /9-D-galactosidase activity in lymphoblastoid cells from two cases of GMr-gangliosidosis were not elevated.
Recently, cultured skin fibroblasts from this patient were revealed to be completely deficient in sialidase (neuraminidase) activity when neuramin lactose, fetuin, methoxyphenylneuraminic acid, [3H] sialylactose or 4MU-a-D-Nacetylneuraminide was used as substrate (Dr. D.A. Wenger, personal communication), although fibroblasts were not available in culture from either of his parents in order to confirm carrier levels for sialidase. Therefore, it was suggested that the observed fl-D-galactosidase deficiency in this patient is due to a severe deficiency of sialidase activity rather than to a primary defect in /3-D-galactosidase and that this patient belongs to a sialidase deficiency with a partial 3-galactosidase defect (Wenger et al. 1978; Okada et al. 1979) .
Patients with sialidase deficiency (so-called "sialidosis") have been reported (Spranger and Cantz 1977; Lowden and O'Brien 1979) . Sialidosis has been clinically classified into type I (normosomatic group) and type II (dysmorphic group) by Lowden and O'Brien (1979) . They considered the present case of variant of /3-galactosidase deficiency to be type II sialidosis. The mechanism responsible for the reduced fl-galactosidase activity in these patients with sialidase deficiency and a partial 9-galactosidase defect remains unknown. Lowden and O'Brien (1979) speculated that the reduced activity of 3-galactosidase is not due to an inhibition by substance stored as a result from sialidase deficiency, but may be caused by a structural mutation of 3-galactosidase. Levels of lysosomal enzyme assayed in lymphoblastoid cells from I-cell disease tended to be lower than those in the control, though there were considerable variations among cases. We had previously found lower levels in only one case of I-cell disease (Minami et al. 1978) .
In summary, the present study showed that the activities of respective deficient enzymes in GMI-gangliosidosis, Gaucher disease, Hurler and Scheie syndrome, and Tay-Sachs disease were barely detectable in lymphoblastoid cells from the patients. Although, as in leukocytes and cultured skin fibroblasts, it was not always possible to detect carrier in lymphoblastoid cells, these cell lines may provide a useful system for basic and biochemical investigation of patients and obligate heterozygotes with lysosomal storage disease. 
